| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | MRPL47 |
| Uniprot No | Q9HD33 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-140 aa |
| 活性数据 | MLLTLEQEAKRQRLPMPSPERLDKVVDSMDALDKVVQEREDALRLLQTGQERARPGAWRRDIFGRIIWHKFKQWVIPWHLNKRYNRKRFFALPYVDHFLRLEREKRARIKARKENLERKKAKILLKKFPHLAEAQKSSLV |
| 分子量 | 43.4 kDa |
| 蛋白标签 | GST-tag at N-terminal |
| 缓冲液 | 0 |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下为关于重组人MRPL47蛋白的参考文献示例(部分基于真实研究综合整理，可能存在虚构细节)：
---
1. **Title**: "Structural insights into the human mitochondrial ribosome assembly: Role of MRPL47 in large subunit biogenesis"
**Authors**: Brown, A. et al. (2016)
**Summary**: 本研究通过冷冻电镜解析了人线粒体核糖体大亚基的结构，揭示MRPL47在亚基组装中的关键作用。作者利用重组表达纯化的MRPL47蛋白进行功能实验，证实其与16S rRNA的结合对维持线粒体翻译活性至关重要。
2. **Title**: "Recombinant expression and functional characterization of MRPL47 in mitochondrial oxidative phosphorylation"
**Authors**: Wang, Y. et al. (2018)
**Summary**: 报道了在大肠杆菌中高效表达重组人MRPL47蛋白的方法，并通过体外重建实验证明其参与线粒体呼吸链复合物I的稳定性。研究提示MRPL47缺陷可能导致细胞能量代谢异常。
3. **Title**: "MRPL47 mutations impair mitochondrial protein synthesis and cause neurological disorders"
**Authors**: Silva, J.P. et al. (2020)
**Summary**: 发现MRPL47基因突变患者表现出脑发育迟缓及线粒体肌病。通过患者细胞系及重组MRPL47蛋白回补实验，证实突变导致蛋白功能丧失，进而破坏线粒体翻译过程。
---
**注**：以上文献为示例性内容，实际引用时建议通过PubMed或Web of Science以"MRPL47"或"mitochondrial ribosomal protein L47"为关键词检索最新研究。
**Recombinant human MRPL47 (Mitochondrial Ribosomal Protein L47)** is a key component of the mitochondrial ribosome, specifically the large 39S subunit, which plays a vital role in mitochondrial protein synthesis. MRPL47 is encoded by nuclear DNA, synthesized in the cytoplasm, and subsequently imported into mitochondria, where it participates in the assembly and stability of the mitochondrial ribosomal structure. This protein is essential for the proper translation of mitochondrial DNA-encoded genes, particularly those involved in oxidative phosphorylation (OXPHOS), a critical process for cellular energy production. Dysregulation of MRPL47 has been linked to mitochondrial dysfunction, which is associated with various human diseases, including metabolic disorders, neurodegenerative conditions, and cancer.
Recombinant MRPL47 is produced using biotechnology platforms, such as *E. coli* or mammalian expression systems*,* enabling researchers to study its structure, interactions, and functional mechanisms in vitro. Its recombinant form is often tagged for purification and detection, facilitating applications in molecular biology, drug discovery, and disease modeling. Studies utilizing recombinant MRPL47 have contributed to understanding mitochondrial ribosome biogenesis, its role in cellular metabolism, and potential therapeutic targets for mitochondrial-related pathologies. However, detailed mechanistic insights into MRPL47's regulatory functions remain an active area of research.
×
